Skincare products maker Nu Skin settles SEC probe
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
The logo of Nu Skin is seen at its "experience centre", where customers can sample and purchase the company's products, in Beijing January 21, 2014. REUTERS/Kim Kyung-Hoon (CHINA - Tags: BUSINESS LOGO)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
(Reuters) - Nu Skin Enterprises Inc (NYSE: NUS) said it had reached an agreement with the Securities and Exchange Commission to settle a probe into the skincare products maker's charitable contribution in China in 2013.
The company also forecast third-quarter revenue at the high-end of its previously issued guidance of $560 million-$580 million.
Nu Skin said it agreed to pay $765,688 to the SEC after the agency found the company's books and internal controls related to the donation were insufficient.
As a part of the agreement, the company neither admitted nor denied the SEC's findings.
Shares of Nu Skin were up 3.6 percent at $61.00 after the bell.
Nu Skin said in February that it would pay $47 million to settle a lawsuit that alleged the company operated a pyramid scheme in China and had made false and misleading statements about its operations.
(Reporting by Abhijith Ganapavaram in Bengaluru; Editing by Shounak Dasgupta)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Third-Party Said Interested in PrivateBancorp (PVTB) as CIBC (CM) Deal is Delayed
- Flowers Foods (FLO) and Flowers Baking Reach Settlement in Class Action Lawsuit
- Recro Pharma (REPH) Plans Offering of Common Stock
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!